April N. Naegeli

April N. Naegeli

Auto-generated profile, based on publicly available information

April N. Naegeli

Eli Lilly and Company , Indianapolis, Indiana , USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2014 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
ANApril N. Naegeli
April N. Naegeli
EFEmuella Flood
Emuella Flood
JTJennifer Tucker
Jennifer Tucker
JDJennifer Devlen
Jennifer Devlen
EEEmily Edson‐Heredia
Emily Edson‐Heredia

1 January 2021 in Crohn's & Colitis 360
Verified
Journal Article
Open access
PDF file
ANApril N Naegeli
April N Naegeli
THTheresa Hunter
Theresa Hunter
YDYan Dong
Yan Dong
BHBen Hoskin
Ben Hoskin
CMChloe Middleton-Dalby
Chloe Middleton-Dalby
JCJames B Canavan
James B Canavan
Background: Understanding ulcerative colitis disease activity assessed via the full, modified, or partial Mayo Score may help clinicians apply results from clinical trials to practice and facilitate interpretation of recent and older studies.Methods: Mayo Score variables were assessed in a cross-sectional study of 2608 ulcerative colitis patients.Results: Permutations of Mayo Scores were highly correlated, and models predicting the omitted variable from each permutation demonstrated significant agreement between predicted and observed values.Conclusions: Partial/modified Mayo Scores may be used to predict endoscopic and Physician’s Global Assessment scores, and serve as proxies for the full Mayo Score in clinical practice/trials.

1 July 2021 in Crohn's & Colitis 360
Verified
Journal Article
Open access
PDF file
GDGhadeer K Dawwas
Ghadeer K Dawwas
HJHamzeh Jajeh
Hamzeh Jajeh
MSMingyang Shan
Mingyang Shan
ANApril N Naegeli
April N Naegeli
THTheresa Hunter
Theresa Hunter
JLJames D Lewis
James D Lewis
Background: In patients with ulcerative colitis (UC) and Crohn’s disease (CD), this research examined the following: prevalence of fecal urgency (hereafter urgency), association of urgency with inflammatory bowel disease (IBD) symptoms and fecal calprotectin, and association between well-being and urgency. Methods: In this cross-sectional study from the Study of a Prospective Adult Research Cohort with IBD, urgency was categorized as none, mild, and moderate-severe. We examined the prevalence of urgency, association of urgency with IBD symptoms and fecal calprotectin (in a subset) using multinomial logistic regression, and association of well-being (not feeling well vs generally well) with urgency using logistic regression. Results: Among 576 UC patients, 31.4% reported mild and 28.1% moderate-severe urgency. Among 1330 CD patients, 33.8% reported mild and 31.4% moderate-severe urgency. In UC, moderate-severe urgency was associated with: increased average bowel movements/day [odds ratio (OR) 1.23; 95% confidence interval: 1.09, 1.23], increased stool frequency relative to normal (OR, 9.95; 95% CI: 3.21, 30.87), rectal bleeding (OR, 3.36; 95% CI: 1.79, 6.34), moderate-severe abdominal pain (OR, 17.5; 95% CI: 5.38, 56.89), and calprotectin ≥ 250 μg/g (OR, 4.36; 95% CI: 1.50, 12.66). In CD, moderate-severe urgency was associated with: increased average bowel movements/day (OR, 1.23; 95% CI: 1.14, 1.34), increased stool frequency relative to normal (OR, 7.57; 95% CI: 3.30, 17.34), rectal bleeding (OR, 1.77; 95% CI: 1.13, 2.78), and moderate-severe abdominal pain (OR, 7.52; 95% CI: 4.31, 13.14). Reduced well-being was associated with moderate-severe urgency in both UC (OR, 4.20; 95% CI: 1.69, 20.40) and CD patients (OR, 2.52; 95% CI: 1.51, 4.22). Conclusions: Urgency was common and associated with symptoms and biomarkers suggesting active IBD and reduced well-being.

1 August 2021 in Gastroenterology
Verified
Journal Article
Open access
PDF file
ADand Marla C. Dubinsky
and Marla C. Dubinsky
RCRory Collins
Rory Collins
MAMaria T. Abreu
Maria T. Abreu
VJVipul Jairath
Vipul Jairath
JLJames D. Lewis
James D. Lewis
EZEllen Zigmont
Ellen Zigmont
Participants completed a survey focused on challenges in the conduct of clinical trials in IBD. The results showed that the greatest challenge in designing and completing studies in IBD was patient recruitment, Danese S. Schabel E. Ainsworth M.A. et al. Challenges and opportunities for IBD drug development: from early stage to regulatory approval. Gut. 2020; 69 : 1157-1161 Crossref PubMed Scopus (4) Google Scholar and it was also noted that the greatest opportunity was innovation in study design. The survey also collected opinions on the relative importance of induction and maintenance endpoints for clinical trials in IBD, and clinical remission was viewed the most important endpoint for both induction and maintenance.

11 November 2013 in Health and Quality of Life Outcomes
Verified
Journal Article
Open access
PDF file
ANApril N Naegeli
April N Naegeli
EFEmuella Flood
Emuella Flood
JTJennifer Tucker
Jennifer Tucker
JDJennifer Devlen
Jennifer Devlen
EEEmily Edson-Heredia
Emily Edson-Heredia
Background: Ankylosing spondylitis (AS) is an autoimmune disorder characterized by inflammation of the spine and large joints. Fatigue is a common symptom that many AS patients find significantly impacts their health-related quality of life. The Worst Fatigue – Numeric Rating Scale (WF-NRS) assesses the severity of this symptom during the previous 24-hour period. The objective of this study was to perform qualitative research to support the development and content validity of the WF-NRS. Methods: Patients with AS were recruited from clinical sites in the U.S. for a qualitative study which first entailed concept elicitation interviews to gain understanding of the patients’ experience with AS and fatigue. Subsequently, cognitive debriefing interviews were undertaken to assess the understandability, clarity, and appropriateness from the patient’s perspective, of the content of a measure of fatigue severity. Results: Thirteen patients with AS participated in concept elicitation interviews and cognitive debriefing of the Brief Fatigue Inventory (BFI) fatigue severity subscale. The WF-NRS was developed from the worst fatigue item of the BFI as patients generally reported it to be understandable and covered an important concept, the completion instructions were modified, but the response scale remained as it was familiar and readily completed, and the recall period was appropriate. Conclusions: Patient responses resulted in the development of and supported the content validity of the WF-NRS. Further quantitative evaluation of the WF-NRS is warranted in order to assess its psychometric properties and confirm its usefulness as a clinical trial tool.

1 March 2010 in Diabetes, Metabolic Syndrome and Obesity
Verified
Journal Article
Open access
PDF file
ANApril N Naegeli
April N Naegeli
TSTimothy E Stump
Timothy E Stump
RHRisa P Hayes
Risa P Hayes
A psychometric evaluation of the Diabetes Symptom Checklist-Revised (DSC-R) cognitive distress, fatigue, hyperglycemia, and hypoglycemia subscales in patients with type 1 and type 2 diabetes April N Naegeli1, Timothy E Stump2, Risa P Hayes11Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN, USA; 2Consultant, Indianapolis, IN, USAObjective: To explore the use of Diabetes Symptom Checklist-Revised (DSC-R) Cognitive Distress, Fatigue, Hyperglycemia, and Hypoglycemia subscales as measures of acute diabetesassociated symptoms in patients with both type 1 and 2 diabetes.Research design and methods: Our study was conducted in context of two international, multicenter, randomized clinical trials for inhaled insulin. Confirmatory factor analyses and assessments of reliability and construct validity were performed.Results: Study participants were 371 patients with type 2 (56% male; mean age, 57 years) and 481 with type 1 diabetes (57% male, mean age, 40 years). In both populations a four-factor model was the best fit. Cronbach’s α ≥ 0.79 and intraclass correlation coefficient ≥0.63; subscales correlated (P ≤ 0.05) with measures of well-being and satisfaction (0.12 ≤ r ≤ 0.71). In patients with type 1 diabetes, three subscales correlated (P < 0.05) with A1C.Conclusions: The psychometric properties of the DSC-R Cognitive Distress, Fatigue, Hyperglycemia, and Hypoglycemia suggest they may be utilized in clinical trials as reliable and valid measures of acute symptoms of diabetes.Keywords: Diabetes Symptom Checklist-Revised, DSC-R, type 1 diabetes, type 2 diabetes, psychometric validation